A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

October 31, 2010

Conditions
Pancreatic CancerBile Duct Cancer
Interventions
DEVICE

Probe-based confocal laser endomicroscopy

ERCP with or without cholangiopancreatoscopy will be performed by the endoscopist as clinically indicated. If findings at ERCP and/or prior imaging studies and/or clinical assessment suggest possible malignancy and/or an indeterminate biliary or pancreatic pathology Cellvizio probe-based endomicroscopy will be performed during ERCP.

Trial Locations (6)

10032

New York Presbyterian Hospital/Columbia University Medical Center, New York

13273

Institut Paoli-Calmettes, Marseille

15213

University of Pittsburgh Medical Center, Pittsburgh

80045

University of Colorado Hospital, Aurora

81675

Klinikum rechts der Isar, Munich

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors
All Listed Sponsors
collaborator

Cellvizio Inc.

INDUSTRY

collaborator

Emissary International LLC

INDUSTRY

lead

Mauna Kea Technologies

INDUSTRY